Citation Impact
Citing Papers
Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.
1991
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Infective Endocarditis
2005 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Recent insights into antiphospholipid antibody-mediated thrombosis
1999
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome
1999
Monoclonal antiphospholipid antibody reactivity against human placental trophoblast
1992
Regulation of microRNA function in animals
2018 Standout
Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration
2014
Zirconia as a ceramic biomaterial
1999 Standout
Immunology of the antiphospholipid antibody syndrome
1996
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Management of the obstetric antiphospholipid syndrome
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics
1989
Evaluation o biocompatibility of various ceramic powders with human fibroblasts in vitro
1993
The Evaluation of Clotting Times in the Laboratory Detection of Lupus Anticoagulants
2001
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormonedependent human chorionic gonadotrophin release by cultured trophoblast cells
1995
Guidelines on the investigation and management of antiphospholipid syndrome
2012
The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events
1999
Oral Contraceptives and the Absolute Risk of Venous Thromboembolism in Women With Single or Multiple Thrombophilic Defects
2007
Heparin-Induced Thrombocytopenia
1998
Purification of antiphospholipid antibodies using a new affinity method
1988
The molecular basis of blood coagulation
1988 Standout
A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer
2011
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System
1998
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Valvular Heart Disease in the Primary Antiphospholipid Syndrome
1992
Clinical characteristics of antiphospholipid antibody syndrome in children
1996
Shedding light on the cell biology of extracellular vesicles
2018 Standout
A simple method to discriminate between β2-glycoprotein I- and prothrombin-dependent lupus anticoagulants
2003
Platelet Activation and Atherothrombosis
2007 Standout
Treatment of von Willebrand's Disease
2004
A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants
2004
The Antiphospholipid Syndrome
2002 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Pre-analytical and analytical issues in the analysis of blood microparticles
2010
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients
1994
Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I
2000
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Differential expression of surface antigens on activated endothelium
1993
Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody- containing sera
1997
Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome
2000
Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
1992
Binding specificity of lupus anticoagulants and anticardiolipin antibodies
1988
Sex differences in autoimmune disease
2001 Standout
Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin–antithrombin III complexes
1997
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass
2007
Thrombophilic screening in young patients (<40years) with idiopathic ischemic stroke: A controlled study
2010
Laboratory diagnosis of the antiphospholipid syndrome
2002
Recurrent miscarriage
2006 Standout
Getting to the site of inflammation: the leukocyte adhesion cascade updated
2007 Standout
The antiphospholipid/cofactor syndromes: A primary variant with antibodies to β2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays
1996
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Reassessment of Exosome Composition
2019 Standout
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis
2004
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
1996
Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies
1991
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Signal Transduction Pathways Mediated by PECAM-1
2003
Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?
1999
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
1991
The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
2000
Nouvelle Cuisine: Platelets Served with Inflammation
2015
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Lupus Anticoagulant Testing in Europe: An Analysis of Results from the First European Concerted Action on Thrombophilia (ECAT) Survey Using Plasmas Spiked with Monoclonal Antibodies against Human β2-Glycoprotein I
1999
Exosomes
2019 Standout
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects
1994
The family history of patients with primary or secondary antiphospholipid syndrome (APS)
2000
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
Platelet microvesicles in health and disease
2017
Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?
1994
Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments
1994
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Antiphospholipid syndrome: five year follow up.
1991
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography
2000
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
1996
Distribution of factor VIII mRNA and antigen in human liver and other tissues
1985 Nature
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
SYSTEMIC LUPUS ERYTHEMATOSUS AND PREGNANCY
1994
Annexins: From Structure to Function
2002 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants
1993
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
1982
The Pathogenesis of Venous Thromboembolism: Evidence for Multiple Interrelated Causes
2006
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Lupus Anticoagulant (LA) Testing: Performance of Clinical Laboratories Assessed by a National Survey Using Lyophilized Affinity-purified Immunoglobulin with LA Activity
2003
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
2000 Standout
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura
1994
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
2010
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
1990 Standout
WHICH PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SHOULD BE TREATED AND HOW?
1993
Direct detection of activated protein C in blood from human subjects
1992
Works of Thomas Exner being referenced
Cell responses to biomaterials II: Endothelial cell adhesion and growth on perfluorosulfonic acid
1988
Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT
2009
Heparin - induced thrombocytopenia: laboratory investigation and confirmation of diagnosis
1992
Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand??s disease
1991
Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column
1988
A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid
2003
Conceptions and Misconceptions in Testing for Lupus Anticoagulants
2000
The coagulation system in placental insufficiency: a study in the fetal circulation
1993
The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib
2010
Comparison of Two Simple Tests for the Lupus Anticoagulant
1985
Monoclonal antibodies to human FVIIIR:Ag and FVIIIC
1985
Measurement of factor VIII CAg by immunoradiometric assay in human tissue extracts
1983
Familial Association of the Lupus Anticoagulant
1980
Scientific and Standardization Committee Communications Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-I (ISLA-1)
1990
Endothelial Cells and Normal Circulating Haemopoietic Cells Share a Number of Surface Antigens
1989
Similar Mechanism of Various Lupus Anticoagulants
1985
Simple immunochromometric assay for protein C activity.
1986
Guidelines for Testing and Revised Criteria for Lupus Anticoagulants
1991
Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor
1975
Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms.
1988
A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns
1978
Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants.
1991